HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 91 filers reported holding HOMOLOGY MEDICINES INC in Q1 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -98.7% | 364 | -98.5% | 0.00% | – |
| Q1 2022 | $75,000 | -16.7% | 24,664 | 0.0% | 0.00% | – |
| Q4 2021 | $90,000 | -53.6% | 24,664 | -0.2% | 0.00% | – |
| Q3 2021 | $194,000 | +8.4% | 24,707 | +0.5% | 0.00% | – |
| Q2 2021 | $179,000 | -21.8% | 24,584 | +1.2% | 0.00% | – |
| Q1 2021 | $229,000 | -34.9% | 24,300 | -22.1% | 0.00% | – |
| Q4 2020 | $352,000 | +5.4% | 31,200 | 0.0% | 0.00% | – |
| Q3 2020 | $334,000 | -29.5% | 31,200 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $474,000 | +21.9% | 31,200 | +24.8% | 0.00% | 0.0% |
| Q1 2020 | $389,000 | -24.9% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $518,000 | +14.3% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $453,000 | -7.4% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $489,000 | +2.5% | 25,000 | +45.3% | 0.00% | 0.0% |
| Q1 2019 | $477,000 | +84.2% | 17,200 | +48.3% | 0.00% | – |
| Q4 2018 | $259,000 | -2.3% | 11,600 | 0.0% | 0.00% | – |
| Q3 2018 | $265,000 | +11.8% | 11,600 | 0.0% | 0.00% | – |
| Q2 2018 | $237,000 | – | 11,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $8,936,000 | 2.21% |
| Vida Ventures Advisors, LLC | 770,845 | $1,519,000 | 1.28% |
| OUP Management Co., LLC | 64,000 | $126,000 | 0.17% |
| Oasis Management Co Ltd. | 280,000 | $552,000 | 0.10% |
| Vivo Capital, LLC | 370,068 | $729,000 | 0.07% |
| AAF Wealth Management, LLC | 47,501 | $94,000 | 0.07% |
| TANG CAPITAL MANAGEMENT LLC | 214,898 | $423,000 | 0.06% |
| Temasek Holdings (Private) Ltd | 5,650,996 | $11,132,462 | 0.06% |
| Bellevue Group AG | 1,622,522 | $3,196,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 128,353 | $253,000 | 0.04% |